E-Debit Global Corp. WSHE Company Overview Stock Message

New Post Public Reply Private Reply Replies (0) Message Board

Sep 6, 2013 at 4:21 PM

E-Debit Global Corp. WSHE Company Overview

Stock Message Board http://investorshangout.com/search?q=WSHE&...mp;yt1=Go!

E-Debit Global Corp. WSHE Current Price and Quotes
Last Price 0.0085
Previous Close 0.0085 Open N/A
Daily Range N/A - N/A 52wk Range 0.05 - 0.0012
Volume 0 Dividend N/A
Average Vol (3m) 132,756 Yield N/A
E-Debit Global Corp. WSHE
Company Information

#12, 3620 - 29 th Street NE
Calgary, ALB T1Y 5Z8
Canada

Website: http://www.edebitglobal.com
Phone: 403-290-0264
Email: shareholder@edebitglobal.com

E-Debit Global Corp. WSHE
E-Debit Globals' subsidiary companies, process debit & credit transactions, deploy an ATM & POS network across Canada.Issue debit, pre-paid and loyalty cards, and continue to grow their presence in the F.I. Industry.

E-Debit Global Corp. WSHE
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001129120
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 6199 - Finance Services
Business Status Development Stage Company a/o Aug 15, 2011
Incorporated In: CO, USA
Year of Inc. 1999
Employees 18 a/o Aug 15, 2011
Company Officers/Contacts

Douglas Mac Donald President, CEO
Kim Law CFO, VP, Fin.
Robert L. Robins VP, Legal
Sonja Dreyer Vice President, Executive Assistant
Company Directors

Douglas Mac Donald
Kim Law
Roy Queen
Bernd Reuscher
Robert L. Robins
John Thomson
Company Notes

Formerly=Westsphere Asset Corp., Inc. until 6-2010
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Dennis Brovarone
18 Mountain Laurel Drive
Littleton, CO, 80127
United States

Investor Relations Firm
Not Available

E-Debit Global Corp. WSHE
WSHE Security Details

Share Structure

Market Value1 $2,720,398 a/o Sep 05, 2013
Shares Outstanding 320,046,834 a/o Jul 30, 2013
Float Not Available
Authorized Shares 500,000,000 a/o Oct 26, 2010
Par Value No Par Value
Shareholders

Shareholders of Record 376 a/o Apr 15, 2013
Security Notes

Capital Change=shs decreased by 1 for 20 split Pay date=04/01/2005.
Capital Change=shs increased by 5 for 1 split, payable upon surrender.. Pay date=11/15/2010.
Short Selling Data

Short Interest 45,775 (-85.68%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)

Holladay Stock Transfer

E-Debit Global Corp. WSHE Recent News

E-Debit Global Corp. WSHE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 2,336 3,346 3,973 3,645
Cost of Revenue 2,117 2,909 3,313 2,869
Gross Profit 219 437 660 775
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 1,141 1,279 1,580 1,479
Non-Recurring Items 480 94 89 54
Other 103 100 80 102
Operating Income (1,506) (1,036) (1,090) (859)
Income From Continuing Operations

Add'l Income/Expense Items 819 90 20 99
Earnings Before Interest and Tax (687) (946) (1,070) (759)
Interest Expense 144 150 83 72
Earnings Before Tax (831) (1,096) (1,153) (832)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (831) (1,096) (1,153) (832)
Non Recurring Events

Discontinued Operations - - - (456)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (831) (1,096) (1,153) (1,288)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (831) (1,096) (1,153) (1,288)

WSHE E-Debit Global Corp. Research DD Guide

WSHE E-Debit Global Corp. Stock Message Board http://investorshangout.com/search?q=WSHE&...mp;yt0=Go!
WSHE E-Debit Global Corp. Stock Quote http://www.otcmarkets.com/stock/WSHE/quote
WSHE E-Debit Global Corp. Stock Chart http://www.otcmarkets.com/stock/WSHE/chart
WSHE E-Debit Global Corp. Company Info http://www.otcmarkets.com/stock/WSHE/company-info
WSHE E-Debit Global Corp. Recent News http://www.otcmarkets.com/stock/WSHE/news
WSHE E-Debit Global Corp. Financials http://www.otcmarkets.com/stock/WSHE/financials
WSHE E-Debit Global Corp. Filings and Disclosure http://www.otcmarkets.com/stock/WSHE/filings
WSHE E-Debit Global Corp. Short Sales http://www.otcmarkets.com/stock/WSHE/short-sales
WSHE E-Debit Global Corp. Insider Disclosure http://www.otcmarkets.com/stock/WSHE/insider-transactions
WSHE E-Debit Global Corp. Research Reports http://www.otcmarkets.com/stock/WSHE/research
WSHE E-Debit Global Corp. Summary http://finance.yahoo.com/q?s=WSHE
WSHE E-Debit Global Corp. Historical Prices http://finance.yahoo.com/q/hp?s=WSHE+Historical+Prices
WSHE E-Debit Global Corp. Interactive Chart http://finance.yahoo.com/echarts?s=WSHE
WSHE E-Debit Global Corp. Basic Chart http://finance.yahoo.com/q/bc?s=WSHE+Basic+Chart
WSHE E-Debit Global Corp. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=WSHE+Basic+Tech.+Analysis
WSHE E-Debit Global Corp. Headlines http://finance.yahoo.com/q/h?s=WSHE+Headlines
WSHE E-Debit Global Corp. Press Releases http://finance.yahoo.com/q/p?s=WSHE+Press+Releases
WSHE E-Debit Global Corp. Company Profile http://finance.yahoo.com/q/pr?s=WSHE+Profile
WSHE E-Debit Global Corp. Key Statistics http://finance.yahoo.com/q/ks?s=WSHE+Key+Statistics
WSHE E-Debit Global Corp. Industry http://finance.yahoo.com/q/in?s=WSHE+Industry
WSHE E-Debit Global Corp. Major Holders http://finance.yahoo.com/q/mh?s=WSHE+Major+Holders
WSHE E-Debit Global Corp. Insider Transactions http://finance.yahoo.com/q/it?s=WSHE+Insider+Transactions
WSHE E-Debit Global Corp. Insider Roster http://finance.yahoo.com/q/ir?s=WSHE+Insider+Roster
WSHE E-Debit Global Corp. Income Statement http://finance.yahoo.com/q/is?s=WSHE
WSHE E-Debit Global Corp. Balance Sheet http://finance.yahoo.com/q/bs?s=WSHE
WSHE E-Debit Global Corp. Cash Flow http://finance.yahoo.com/q/cf?s=WSHE+Cash+Flow&annual
WSHE E-Debit Global Corp. Nasdaq http://www.nasdaq.com/symbol/WSHE
WSHE E-Debit Global Corp. Market Watch http://www.marketwatch.com/investing/stock/WSHE
WSHE E-Debit Global Corp. Bloomberg http://www.bloomberg.com/quote/WSHE:US
WSHE E-Debit Global Corp. Morningstar http://quotes.morningstar.com/stock/s?t=WSHE
WSHE E-Debit Global Corp. Bussinessweek http://investing.businessweek.com/research/st...icker=WSHE
WSHE E-Debit Global Corp. Barchart http://www.barchart.com/quotes/stocks/WSHE
WSHE E-Debit Global Corp. OTC Short Report http://otcshortreport.com/index.php?index=WSHE
WSHE E-Debit Global Corp. Investopedia http://www.investopedia.com/markets/stocks/WSHE/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...